These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Rummeny EJ, Torres CG, Kurdziel JC, Nilsen G, Op de Beeck B, Lundby B. Acta Radiol; 1997 Jul; 38(4 Pt 2):638-42. PubMed ID: 9245957 [Abstract] [Full Text] [Related]
7. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R. Eur Radiol; 2000 Jul; 10(11):1697-702. PubMed ID: 11097390 [Abstract] [Full Text] [Related]
8. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Wang C, Gordon PB, Hustvedt SO, Grant D, Sterud AT, Martinsen I, Ahlström H, Hemmingsson A. Acta Radiol; 1997 Jul; 38(4 Pt 2):665-76. PubMed ID: 9245962 [Abstract] [Full Text] [Related]
19. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging. Federle M, Chezmar J, Rubin DL, Weinreb J, Freeny P, Schmiedl UP, Brown JJ, Borrello JA, Lee JK, Semelka RC, Mattrey R, Dachman AH, Saini S, Harms SE, Mitchell DG, Anderson MW, Halford HH, Bennett WF, Young SW, Rifkin M, Gay SB, Ballerini R, Sherwin PF, Robison RO. J Magn Reson Imaging; 2000 Nov; 12(5):689-701. PubMed ID: 11050638 [Abstract] [Full Text] [Related]
20. Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions. Eser G, Karabacakoglu A, Karakose S, Eser C, Kayacetin E. World J Gastroenterol; 2006 Mar 14; 12(10):1603-6. PubMed ID: 16570354 [Abstract] [Full Text] [Related] Page: [Next] [New Search]